BHARAT IMMUNOLOGICALS (India) Probability of Target Price Finishing Over 6.98

BIBCL -- India Stock  

INR 6.50  0.80  10.96%

BHARAT IMMUNOLOGICALS probability of target price tool provides mechanism to make assumptions about upside and downside potential of BHARAT IMMUNOLOGICALS BIOLOG performance during a given time horizon utilizing its historical volatility. Please specify BHARAT IMMUNOLOGICALS time horizon, a valid symbol (red box) and a target price (blue box) you would like BHARAT IMMUNOLOGICALS odds to be computed. Check also Trending Equities.
Horizon     30 Days    Login   to change
Refresh Odds

BHARAT IMMUNOLOGICALS Target Price Odds to finish over 6.98

Current PriceHorizonTarget PriceOdds to move over  6.98  or more in 30 days
 6.50 30 days 6.98 
ABOUT 57.9%
Based on normal probability distribution, the odds of BHARAT IMMUNOLOGICALS to move over  6.98  or more in 30 days from now is about 57.9% (This BHARAT IMMUNOLOGICALS BIOLOG probability density function shows the probability of BHARAT IMMUNOLOGICALS Stock to fall within a particular range of prices over 30 days) . Probability of BHARAT IMMUNOLOGICALS price to stay between its current price of  6.50  and  6.98  at the end of the 30-day period is about 25.1%.
Assuming 30 trading days horizon, the stock has beta coefficient of 1.609 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average . However, if the benchmark returns are expected to be negative, BHARAT IMMUNOLOGICALS will likely underperform. Additionally The company has a negative alpha implying that the risk taken by holding this equity is not justified. BHARAT IMMUNOLOGICALS is significantly underperforming DOW.
Alpha over DOW
Beta against DOW=1.61
Overall volatility
Information ratio =0.06

BHARAT IMMUNOLOGICALS Alerts and Suggestions

BHARAT IMMUNOLOGICALS is not yet fully synchronised with the market data
BHARAT IMMUNOLOGICALS generates negative expected return over the last 30 days
BHARAT IMMUNOLOGICALS has high historical volatility and very poor performance
BHARAT IMMUNOLOGICALS has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 836.45M. Net Loss for the year was (55.57M) with profit before overhead, payroll, taxes, and interest of 103.65M.


Float Shares17.57M
Average Daily Volume Last 10 Day7.95k
Average Daily Volume In Three Month13.71k